611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Women's Health
Basic InformationLatest News
Depression During Menopause: How to Spot It and Treat ItPandemic Has Many Women Holding Back on Motherhood, NYC Study FindsIs Hysterectomy Always Needed for a Common, Painful Gynecologic Condition?Your State's Laws Might Save Your Life If Breast Cancer StrikesMom-to-Be's 'Leaky' Heart Valves May Pose More Danger Than ThoughtMore College-Educated Women Are Having Children Outside of MarriageAI May Not Be Ready to Accurately Read MammogramsPandemic Brought Big Drop in Breast Cancer Screening in Older, Low-Income WomenWomen May Find It Tougher to Quit Smoking Than MenFor Better Breastfeeding, 'Lactation Consultants' Can HelpCOVID Vaccine Safe, Recommended for Pregnant Women, CDC SaysCould Women's Health Decline Along With Their Height?Women Less Likely to Get Best Care for Deadly Form of StrokeHRT Could Raise Odds for AsthmaLeading U.S. Ob-Gyn Groups Urge COVID Vaccines for All Pregnant WomenAcne Can Take Big Emotional Toll on WomenVitamin D May Lower Black Women's Odds for COVID-19Mom's Weight-Loss Surgery Lowers Many Pregnancy Complications, Raises OthersPregnant Women Need to Take Care in Sweltering Summer HeatAre Antibiotics Really the Answer for UTIs in Women?Stronger Hearts, Better Outcomes in Pregnancy: StudyCould Menopausal Hormone Therapy Reduce Women's Odds for Dementia?Screening Often Misses Endometrial Cancer in Black WomenAHA News: Pregnant Mom's Diet May Influence Baby's Cardiovascular HealthPandemic Delays in Screening Mean More Breast Cancer Deaths Ahead: StudyUrinary Incontinence Can Affect a Woman's Mental HealthCOVID Vaccine Doesn't Infiltrate Breast MilkGap in Breast Cancer Survival for Black, White Patients Shrinks, But Not by EnoughCost a Barrier to Cervical Cancer Screening for Many U.S. WomenAlcohol Still a Threat in Too Many American Pregnancies: StudyWomen's Cancer Screenings Plummeted During PandemicPandemic Day Care Closures Forced 600,000 U.S. Working Moms to Leave JobsNo Sign Prior COVID Infection Affects a Woman's Fertility: StudyFertility Drugs Won't Raise Breast Cancer RiskMigraines Tied to Higher Odds for Complications in PregnancyWomen, Take These Key Steps to Good Urological HealthAre Women Absorbing Toxins From Their Makeup?Race Doesn't Affect Risk for Genes That Raise Breast Cancer RiskHealthy Levels of Vitamin D May Boost Breast Cancer OutcomesHeavy Drinking Could Lower a Woman's Odds of ConceptionAHA News: Asian and Pacific Islander Women May Be at Greatest Risk for Preeclampsia ComplicationsFibroid Pain, Bleeding Is Driving Thousands of Women to the ERA Woman's Diet Might Help Her Avoid Breast CancerBreast Cancer's Spread Is More Likely in Black Women, Study FindsDrug Lynparza Could Help Fight Some Early-Stage Breast CancersAHA News: Menopause Before 40 Tied to Higher Stroke RiskHealthy Eating Lowers Pregnancy Complication RiskAortic Tears Are Even More Deadly for Women, Study FindsFDA Warns of Bogus Fertility Claims for Some SupplementsAHA News: Surprisingly Few Women May Have Good Heart Health Before Pregnancy
Questions and AnswersLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Wellness and Personal Development
Mental Disorders

IVF Won't Raise Ovarian Cancer Risk: Study

HealthDay News
by Robert Preidt
Updated: Nov 19th 2020

new article illustration

THURSDAY, Nov. 19, 2020 (HealthDay News) -- Fertility treatments such as in vitro fertilization don't appear to increase a woman's risk of ovarian cancer, a new study finds.

Previous studies suggested that women who used this assisted reproductive technologies (ART) such as IVF to get pregnant may be at risk for ovarian cancer and non-malignant borderline tumors, due to increased levels of sex hormones needed to stimulate egg production, as well as multiple punctures disrupting ovarian tissue.

ART involves removing eggs from a woman's ovaries surgically, fertilizing them in a lab and then placing them in the womb.

In this study, researchers analyzed data from the Netherlands to compare more than 30,600 women who received ovarian stimulation for ART between 1983 and 2001 and nearly 10,000 infertile women who didn't receive such treatment.

After a median follow-up of 24 years, the women had 158 invasive cancers and 100 borderline ovarian tumors. (Median means half were followed longer, half for less time.)

Significantly, women who had ART did not have a higher cancer risk than infertile women who did not have ART -- even after more than 20 years had passed.

Compared with women in the general population, women who used ART did have a higher ovarian cancer risk.

Researchers said this was mainly because a higher proportion of women who received ART never had children. Childlessness has been shown to be a strong risk factor for ovarian cancer, according to authors of the study published Nov. 17 in JNCI: Journal of the National Cancer Institute.

They also found that the risk of ovarian cancer decreased among women with a larger number of successful ART cycles that resulted in childbirth.

Compared with women in the general population and infertile women who didn't have ART, women who had ART had almost double the odds for borderline ovarian tumors, according to the study.

But the risk didn't rise after more treatment cycles or longer follow-up, suggesting that it might owe to underlying patient characteristics rather than ART itself, according to the researchers.

Borderline tumors are rare in the general population and generally easy to treat, they noted.

"Reassuringly, women who received ovarian stimulation for assisted reproductive technology do not have an increased risk of malignant ovarian cancer, not even in the long run," said lead author Flora van Leeuwen, an epidemiologist at the Netherlands Cancer Institute in Amsterdam.

"However, it is important to realize that even with the long follow-up in our study, the median age of the women at end of follow-up was only 56 years," she said in a journal news release.

Noting that the incidence of ovarian cancer in the population increases at older ages, van Leeuwen said it is important to follow women who have had ART even longer.

More information

For more on ovarian cancer, see the American Cancer Society.

SOURCE: JNCI: Journal of the National Cancer Institute, news release, Nov. 17, 2020